News
-
-
-
COMMUNIQUÉ DE PRESSE
New Innovators with Jane King Interview with Jaguar Health CEO Lisa Conte Spotlights Company’s Near-Term Commercial & Development Milestones
Jaguar Health, Inc. announces near-term activities including Gelclair launch and crofelemer trials for rare diseases. Includes Lisa Conte interview details -
-
-
COMMUNIQUÉ DE PRESSE
Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital
Disclosure of total voting rights and capital by EUROFINS SCIENTIFIC SE including changes from cancellation of beneficiary units and treasury share purchase -
-
COMMUNIQUÉ DE PRESSE
Introducing Crush Social: A New Network to Usher in a New Era of Social Media
Crush Social, a new social networking platform, prioritizes privacy, content ownership, and freedom of expression. Developed by a global team, it offers unique music integration and a diverse user experience -
-
